March 3 (Reuters) - FDA:
FDA: PHILIPS REMOVES, DISCONTINUES DISTRIBUTION OF TACK ENDOVASCULAR SYSTEM DUE TO USER CHALLENGES THAT CAUSED ADDITIONAL PROCEDURES TO REPOSITION
FDA: 20 REPORTED INJURIES RELATED TO PHILIPS TACK ENDOVASCULAR SYSTEM ISSUE - WEBSITE
FDA: IDENTIFIED PHILIPS' TACK ENDOVASCULAR SYSTEM RECALL AS MOST SERIOUS TYPE
Source text: [ID:]
Further company coverage: PHG.AS